In short
This article discusses a clinical trial investigating the use of Aconite Pain Oil, which contains D-Camphor as one of its active ingredients, in cancer patients undergoing chemotherapy. The study aims to prevent and reduce symptoms of chemotherapy-induced polyneuropathy (CIPN) and improve patients' quality of life. The trial is designed to compare the effectiveness of the Aconite Pain Oil against a placebo in managing CIPN symptoms and potentially reducing the risk of developing severe CIPN.
At a glance
- Study Type
- Prospective, placebo-controlled clinical trial
- Main Objective
- Reduce risk of CIPN grade II and higher by 35% using Aconite Pain Oil compared to placebo
- Treatment
- Aconite Pain Oil containing D-Camphor, applied externally
- Dosage
- Up to 12 ml per day for up to 7 months
- Key Inclusion Criteria
- Age 18+, solid tumors, scheduled for specific chemotherapy, Karnofsky Index ≥70%
- Primary Endpoint
- Time to CIPN of grade II or higher
- Secondary Endpoints
- Quality of life, sleep quality, anxiety and depression levels, patient satisfaction
What is Aconite Pain Oil?
Aconite Pain Oil, also known as "Aconit Schmerzöl" in German, is a medicinal product being studied for its potential to prevent and reduce symptoms of chemotherapy-induced polyneuropathy (CIPN) in cancer patients. This oil contains several active ingredients, including:
- D-CAMPHOR: A natural compound derived from the camphor tree, known for its pain-relieving properties
- Lavender Oil: An essential oil with potential calming and pain-relieving effects
- Quartz: Used in a highly diluted form according to homeopathic principles
- Aconitum napellus: A plant-based ingredient prepared using anthroposophic methods
Intended Use
Aconite Pain Oil is being investigated as a treatment for chemotherapy-induced polyneuropathy (CIPN). CIPN is a common side effect of certain chemotherapy drugs, particularly taxanes and platinum derivatives, which can cause nerve damage leading to pain, numbness, and tingling in the hands and feet.
How It Works
While the exact mechanism of action is still being studied, Aconite Pain Oil is believed to work through a combination of its active ingredients. The camphor and lavender oil may provide local pain relief and improve circulation, while the homeopathic and anthroposophic components are thought to stimulate the body's self-healing processes.
Clinical Trial Details
A clinical trial is currently underway to evaluate the effectiveness of Aconite Pain Oil in preventing and treating CIPN. The study aims to determine if the oil can:
- Reduce the risk of developing grade II or higher CIPN by 35% compared to a placebo
- Improve quality of life for patients undergoing chemotherapy
- Enhance sleep quality
- Reduce anxiety and depression associated with CIPN
Potential Benefits
If proven effective, Aconite Pain Oil could offer several benefits for cancer patients undergoing chemotherapy:
- Prevention or reduction of CIPN symptoms
- Improved quality of life during and after chemotherapy
- Better sleep
- Reduced anxiety and depression
- Potentially fewer chemotherapy dose reductions or discontinuations due to CIPN
Administration
Aconite Pain Oil is applied externally to the skin. In the clinical trial, patients use a dosing cup to measure the specific volume of oil to be applied. The maximum daily dose is 12 ml, and the treatment period can last up to 7 months.
Who Can Use It?
The clinical trial is focusing on adult cancer patients (18 years or older) with solid tumors who are scheduled to receive chemotherapy with taxanes or platinum derivatives for at least 3 months. Patients must have a good overall health status (Karnofsky Index ≥ 70%) and an expected life expectancy of at least 12 months.
Precautions
Aconite Pain Oil may not be suitable for everyone. The clinical trial excludes patients with:
- Previous or current neurotoxic medication use
- Certain comorbidities like inadequately treated diabetes or renal insufficiency
- Active infectious diseases
- Neurological diseases that could interfere with CIPN assessment
- Known hypersensitivity to camphor or any other ingredients in the oil
- Pregnancy or breastfeeding
It's important to note that Aconite Pain Oil is still being studied and is not yet approved for general use. Patients should always consult with their healthcare provider before considering any new treatments for CIPN or other chemotherapy side effects.